Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.
Related Research units
Abstract
Therapeutic regimens are being developed for patients with hepatitis C virus (HCV) infection that do not include the combination of peginterferon alfa and ribavirin. We investigated the antiviral effect and safety of BI 201335 (an inhibitor of the NS3/4A protease) and BI 207127 (an inhibitor of the NS5B non-nucleoside polymerase) with ribavirin.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 6 |
| ISSN | 0016-5085 |
| Publication status | Published - 2011 |
| pubmed | 21925126 |
|---|
